Ionis’ New Role Is Managing Success

PHARMA: Partnerships and Promising Pipeline Boost Co.

When Stanley Crooke formed Ionis Pharmaceuticals in 1989, he saw the venture as a longshot. He told investors as much.

Tease photo

Escient Pharmaceuticals Snags $40M Series A Round

San Diego-based Escient Pharmaceuticals launched with a $40 million Series A round, which will go toward a pipeline of novel drugs.

Neurana Pharmaceuticals Raises $60 Million in Series A Round

San Diego-based Neurana Pharmaceuticals raised $60 million in Series A financing for a relaxant that treats acute, painful muscle spasms.

Luna DNA Raises $2 Million in New Investment Round

Solana Beach-based Luna DNA raised $2 million in a new round of funding, led by Illumina Ventures and Arch Venture Partners, it was announced May 8.

Maravai LifeSciences Expands Top Management Team with 4 New Execs

The new hires have assumed key positions in two of Maravai LifeSciences operating businesses: TriLink BioTechnologies and Cygnus Technologies.

CalciMedica Names Two Senior Executives to its Board

CalciMedica focuses on calcium release-activated calcium (CRAC) channel drug discovery and development for the treatment of acute and chronic inflammatory diseases.

San Diego Blood Bank, Seqster Partner to Provide Donors Access to Integrated Health Data

Seqster's platform standardizes data from electronic medical records (EMRs), wearables, such as FitBit, and genomics reports, such as those produced by companies such as 23andMe.

Scripps Translational Science Institute Awarded $34 Million

The Scripps Translational Science Institute (STSI) was awarded $34 million in renewed funding to advance genomic and digital technologies in clinical care.

AMN Healthcare Reports Q1 Results

AMN Healthcare reported $522 million in quarter one revenue, up 6 percent year over year, fueled by higher-than-expected staffing needs.

In China, Biotechs Take Partnership Path

TRADE: S.D. Cos. Able to Avoid Some of the Complexities

San Diego biotechs are inking deals with Chinese firms to tap into China’s ever-growing demand for groundbreaking drugs.

Tease photo

Q1: Dexcom Revenue Jumps 30%

San Diego-based Dexcom reported a 30 percent year-over-year revenue increase in quarter one results due a sharp increase in international sales.

NuVasive Reports Q1 Results

NuVasive reported $260.5 million in quarter one results, a 4.6 percent year-over year increase, with its core U.S. hardware business showing solid growth.

Dermtreat Appoints New CEO, Establishes HQ in S.D.

Nishan de Silva has nearly 20 years of experience in biotechnology, venture capital and healthcare management consulting.

Synthorx Raises $63 Million in Series C Round

San Diego-based Synthorx — formed around synthetic biology for novel protein therapies — raised $63 million in a Series C round.

UC San Diego Receives $4.7M Gift for Medical Cannabis Research

New study will look at CBD as a treatment for severe autism.